304 related articles for article (PubMed ID: 27470631)
1. [Clinical features of drug-induced autoimmune hepatitis and drug-induced liver injury: a comparative analysis].
Zhao SX; Zhang YG; Tan PF; Wang RQ; Nan YM
Zhonghua Gan Zang Bing Za Zhi; 2016 Apr; 24(4):302-6. PubMed ID: 27470631
[TBL] [Abstract][Full Text] [Related]
2. [Serological and pathological features of drug-induced liver injury and autoimmune hepatitis].
Jiang ZL; Li P; Wang JL; Yang QH; Liu YG; Shi RF; Mi YQ
Zhonghua Gan Zang Bing Za Zhi; 2016 Nov; 24(11):810-816. PubMed ID: 27978925
[No Abstract] [Full Text] [Related]
3. The clinical features of drug-induced liver injury observed through liver biopsy: focus on relevancy to autoimmune hepatitis.
Ju HY; Jang JY; Jeong SW; Woo SA; Kong MG; Jang HY; Lee SH; Kim SG; Cha SW; Kim YS; Cho YD; Jin SY; Kim HS; Kim BS
Clin Mol Hepatol; 2012 Jun; 18(2):213-8. PubMed ID: 22893872
[TBL] [Abstract][Full Text] [Related]
4. A case of synthetic oestrogen-induced autoimmune hepatitis with microvesicular steatosis.
Morii K; Nishisaka M; Nakamura S; Oda T; Aoyama Y; Yamamoto T; Kishida H; Okushin H; Uesaka K
J Clin Pharm Ther; 2014 Oct; 39(5):573-6. PubMed ID: 24989642
[TBL] [Abstract][Full Text] [Related]
5. Persistent liver biochemistry abnormalities are more common in older patients and those with cholestatic drug induced liver injury.
Fontana RJ; Hayashi PH; Barnhart H; Kleiner DE; Reddy KR; Chalasani N; Lee WM; Stolz A; Phillips T; Serrano J; Watkins PB;
Am J Gastroenterol; 2015 Oct; 110(10):1450-9. PubMed ID: 26346867
[TBL] [Abstract][Full Text] [Related]
6. [Clinical features of autoimmune hepatitis patients with poor response to treatment].
Zhang HW; Liu HM; Lin R; Zhou L; Zhang J; Liu WT
Zhonghua Gan Zang Bing Za Zhi; 2017 Oct; 25(10):755-759. PubMed ID: 29108204
[No Abstract] [Full Text] [Related]
7. Clinical characteristics of drug-induced liver injury and primary biliary cirrhosis.
Yang J; Yu YL; Jin Y; Zhang Y; Zheng CQ
World J Gastroenterol; 2016 Sep; 22(33):7579-86. PubMed ID: 27672278
[TBL] [Abstract][Full Text] [Related]
8. ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries.
Kwo PY; Cohen SM; Lim JK
Am J Gastroenterol; 2017 Jan; 112(1):18-35. PubMed ID: 27995906
[TBL] [Abstract][Full Text] [Related]
9. The value of serum aspartate aminotransferase and gamma-glutamyl transpetidase as biomarkers in hepatotoxicity.
Robles-Diaz M; Garcia-Cortes M; Medina-Caliz I; Gonzalez-Jimenez A; Gonzalez-Grande R; Navarro JM; Castiella A; Zapata EM; Romero-Gomez M; Blanco S; Soriano G; Hidalgo R; Ortega-Torres M; Clavijo E; Bermudez-Ruiz PM; Lucena MI; Andrade RJ; ;
Liver Int; 2015 Nov; 35(11):2474-82. PubMed ID: 25809419
[TBL] [Abstract][Full Text] [Related]
10. Clinical features of autoimmune hepatitis with acute presentation: a Japanese nationwide survey.
Joshita S; Yoshizawa K; Umemura T; Ohira H; Takahashi A; Harada K; Hiep NC; Tsuneyama K; Kage M; Nakano M; Kang JH; Koike K; Zeniya M; Yasunaka T; Takaki A; Torimura T; Abe M; Yokosuka O; Tanaka A; Takikawa H;
J Gastroenterol; 2018 Sep; 53(9):1079-1088. PubMed ID: 29476251
[TBL] [Abstract][Full Text] [Related]
11. Re-analysis of clinical features of 89 patients with autoimmune hepatitis using the revised scoring system proposed by the International Autoimmune Hepatitis Group.
Omagari K; Masuda J; Kato Y; Nakata K; Kanematsu T; Kusumoto Y; Mori I; Furukawa R; Tanioka H; Tajima H; Koga M; Yano M; Kohno S
Intern Med; 2000 Dec; 39(12):1008-12. PubMed ID: 11197782
[TBL] [Abstract][Full Text] [Related]
12. [Elevation of liver enzymes in a patient with chronic hepatitis B during alpha-interferon treatment: what is it all about?].
Tiesmeier J; Dienes HP; Schuppert F
MMW Fortschr Med; 2009 Sep; 151(37):48-50. PubMed ID: 19827430
[No Abstract] [Full Text] [Related]
13. Clinical and Pathological Characteristics of Autoimmune Hepatitis with Acute Presentation.
Shen Y; Lu C; Men R; Liu J; Ye T; Yang L
Can J Gastroenterol Hepatol; 2018; 2018():3513206. PubMed ID: 29744332
[No Abstract] [Full Text] [Related]
14. [Sudden rise in liver transaminase activities].
Holstege A
MMW Fortschr Med; 2014 Feb; 156(3):62-3. PubMed ID: 24938069
[No Abstract] [Full Text] [Related]
15. [A clinical analysis of 22 patients with drug-induced liver injury caused by traditional Chinese medicine Periploca forrestii Schltr].
Feng JC; Wang HY; Zhou AQ; Wang DX; Xie Q; Jiang H; Qian GM
Zhonghua Gan Zang Bing Za Zhi; 2016 Sep; 24(9):692-695. PubMed ID: 27788727
[No Abstract] [Full Text] [Related]
16. Autoimmune hepatitis in human immunodeficiency virus-infected patients: A case series and review of the literature.
Chaiteerakij R; Sanpawat A; Avihingsanon A; Treeprasertsuk S
World J Gastroenterol; 2019 Sep; 25(35):5388-5402. PubMed ID: 31558881
[TBL] [Abstract][Full Text] [Related]
17. CD4
Qu LM; Wang SH; Yang K; Brigstock DR; Sun L; Gao RP
Hepatobiliary Pancreat Dis Int; 2018 Apr; 17(2):133-139. PubMed ID: 29551296
[TBL] [Abstract][Full Text] [Related]
18. [Clinical and pathological analysis of primary biliary cirrhosis-autoimmune hepatitis overlap syndrome].
Wu CH; Xu XY; Lu HY; Yu YY; Wang GQ
Beijing Da Xue Xue Bao Yi Xue Ban; 2004 Dec; 36(6):609-11. PubMed ID: 15605092
[TBL] [Abstract][Full Text] [Related]
19. [Clinical characteristics and prognosis analysis of 498 cases with drug-induced liver injury].
Yang X; Tu RF; Yang JH
Zhonghua Gan Zang Bing Za Zhi; 2022 Jul; 30(7):735-740. PubMed ID: 36038343
[No Abstract] [Full Text] [Related]
20. Drug-induced liver injury with autoimmune features complicated with hemophagocytic syndrome.
Hayashi M; Abe K; Imaizumi H; Okai K; Kanno Y; Takahashi A; Ohira H
Clin J Gastroenterol; 2016 Jun; 9(3):150-5. PubMed ID: 27076346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
